BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8268032)

  • 1. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma exchange in neurology.
    Uldry PA; Steck AJ
    Curr Stud Hematol Blood Transfus; 1990; (57):167-83. PubMed ID: 2272200
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurologic indications for therapeutic plasma exchange: 2011 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma exchange in the treatment of patients with immunoneurologic disorders].
    Balint B; Radović M; Jovicić A; Apostolski S; Milenković L; Taseski J
    Vojnosanit Pregl; 1990; 47(5):348-51. PubMed ID: 2288110
    [No Abstract]   [Full Text] [Related]  

  • 5. The utility of therapeutic plasmapheresis for neurological disorders.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(4):1-7. PubMed ID: 3537747
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracorporeal antibody elimination in neuroimmunological diseases.
    Toepfer M; Schiffl H; Sitter T; Pongratz D; Müller-Felber W
    Ther Apher; 1999 Aug; 3(3):268-70. PubMed ID: 10427627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic apheresis in neurological disorders.
    Weinstein R
    J Clin Apher; 2000; 15(1-2):74-128. PubMed ID: 10767052
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic plasma exchange in neurologic disorders.
    Kes P
    Acta Med Croatica; 1997; 51(4-5):225-8. PubMed ID: 9473803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange.
    Shumak KH; Rock GA
    N Engl J Med; 1984 Mar; 310(12):762-71. PubMed ID: 6199669
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders.
    Katz J; Barohn RJ
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):381-97. PubMed ID: 11345014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application and the technical procedure of plasmapheresis].
    Gurland HJ; Samtleben W
    Internist (Berl); 1983 Jan; 24(1):14-26. PubMed ID: 6341277
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic plasma exchange: indications and results].
    Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G
    Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune diseases of the neuroimmune system and mental disease.
    Steiner I; Abramsky O
    Immunol Ser; 1989; 45():491-511. PubMed ID: 2488144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasmapheresis in neurological diseases].
    Oikarinen R
    Duodecim; 1990; 106(7):553-4. PubMed ID: 1670211
    [No Abstract]   [Full Text] [Related]  

  • 16. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development.
    JAMA; 1986 Sep; 256(10):1333-7. PubMed ID: 3747048
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with plasmapheresis in 153 neurologic patients.
    Dau PC; Miller RG; Denys EH
    Int J Artif Organs; 1982 Jan; 5(1):37-46. PubMed ID: 7068264
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma exchange in neurological diseases.
    Behan PO; Behan WM
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):283-4. PubMed ID: 3115412
    [No Abstract]   [Full Text] [Related]  

  • 20. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.